Cargando…

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis

BACKGROUND: Raloxifene and alendronate are anti-resorptive therapies approved for the prevention and treatment of postmenopausal osteoporosis. Raloxifene is also indicated to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foster, Shonda A, Shi, Nianwen, Curkendall, Suellen, Stock, John, Chu, Bong-Chul, Burge, Russel, Diakun, David R, Krege, John H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626542/ https://www.ncbi.nlm.nih.gov/pubmed/23521803 http://dx.doi.org/10.1186/1472-6874-13-15

Ejemplares similares

Alendronate and Raloxifene Therapy in the Early Period after Hip Fracture
por: Ohishi, Tsuyoshi, et al.
Publicado: (2011)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

Effects of the Combination Treatment of Raloxifene and Alendronate on the Biomechanical Properties of Vertebral Bone
por: Diab, Tamim, et al.
Publicado: (2011)

Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol
por: Bitto, A, et al.
Publicado: (2008)

Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model
por: Allen, Matthew R., et al.
Publicado: (2017)

Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003)

Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates
por: Foster, Shonda A, et al.
Publicado: (2008)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara, Saeko, et al.
Publicado: (2014)

Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials
por: Lin, Tiao, et al.
Publicado: (2014)

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study
por: Hazel-Fernandez, Leslie, et al.
Publicado: (2013)

Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2008)

Psychometric properties of the osteoporosis assessment questionnaire (OPAQ) 2.0: results from the multiple outcomes of raloxifene evaluation (MORE) study
por: Shen, Wei, et al.
Publicado: (2014)

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States
por: Burge, R. T., et al.
Publicado: (2016)

Use of health-related quality of life measures to predict health utility in postmenopausal osteoporotic women: results from the Multiple Outcomes of Raloxifene Evaluation study
por: Burge, Russel, et al.
Publicado: (2013)

Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
por: Bonafede, Machaon M, et al.
Publicado: (2011)

A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures
por: Bonafede, Machaon MK, et al.
Publicado: (2010)

Co‐consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants
por: Clarke, John D., et al.
Publicado: (2023)

Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization
por: Armstrong, April W., et al.
Publicado: (2018)

Raloxifene in Hemodialysis Patients
por: Keller, Frieder
Publicado: (2012)

Oxidative Stress and Raloxifene
por: Akgol, Gurkan, et al.
Publicado: (2012)

Atypical fracture of the ulna associated with alendronate use
por: Bjørgul, Kristian, et al.
Publicado: (2011)

Retrospective Analysis of Long-Term Adherence to and Persistence with DPP-4 Inhibitors in US Adults with Type 2 Diabetes Mellitus
por: Farr, Amanda M., et al.
Publicado: (2014)

Tibia shaft fractures: costly burden of nonunions
por: Antonova, Evgeniya, et al.
Publicado: (2013)

Healthcare Costs Among Patients with Psoriasis Treated with Ixekizumab Versus Secukinumab in Real-World Settings Over 24 Months
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Safety of Raloxifene in Hemodialysis Patients
por: Jacobsen, Didy
Publicado: (2012)

Comparison of Real-World Treatment Patterns Among Biologic-Experienced Patients with Psoriasis Treated with Ixekizumab or Secukinumab Over 18 Months
por: Blauvelt, Andrew, et al.
Publicado: (2021)

Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab
por: Blauvelt, Andrew, et al.
Publicado: (2020)

Nickel alendronate
por: Sikorska, Małgorzata, et al.
Publicado: (2012)

Hemostatic Effects of Raloxifene in Ovariectomized Rats
por: Alva-Chavarría, Denys, et al.
Publicado: (2023)

Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States
por: Hiligsmann, Mickaël, et al.
Publicado: (2023)

Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
por: Mok, Ji Oh, et al.
Publicado: (2013)

Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan
por: Mori, Takahiro, et al.
Publicado: (2021)

Inpatient cost of treating osteoporotic fractures in mainland China: a descriptive analysis
por: Yang, Yicheng, et al.
Publicado: (2015)

Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
por: Shin, Chang Jin, et al.
Publicado: (2016)

Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats
por: Vashghani Farahani, Mohammad-Mahdi, et al.
Publicado: (2019)

Association between alendronate and atypical femur fractures: a meta-analysis
por: Liu, Lu, et al.
Publicado: (2015)

Meta-regression analysis of the efficacy of alendronate for prevention of glucocorticoid-induced fractures
por: Qiu, Mei, et al.
Publicado: (2020)

Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection
por: Allegretti, Marcello, et al.
Publicado: (2021)

Comparison of Real-World Costs, Healthcare Resource Utilization, and Comorbidity-Related Costs Between Ixekizumab and Secukinumab Among Biologic-Experienced Patients with Psoriasis Over 18 Months in the USA
por: Blauvelt, Andrew, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4os1j4en8mlqudrv5na4ioss26